How many of TrueHealth’s percutaneous robotic systems have nationwide NMPA approvals?

Question

Accepted Answer

TrueHealth Medical Holds Five Nationwide NMPA Approvals for Percutaneous Robotic Systems

As of the latest practicable date, TrueHealth Medical has secured five nationwide approvals from the National Medical Products Administration (NMPA) for its percutaneous surgical robotic systems. This positions the company as the earliest and most prolific developer of such cleared devices within this specialised medical technology segment.
Diverse Product Portfolio

The company's approved robotic systems include four variants of its flagship percutaneous surgical robot lineup: TH-S1, TH-S, TH-S Pro, and TH-SA. Additionally, its percutaneous microwave ablation robotics pipeline has also yielded approvals, notably the TH-X MW system for liver and lung tumor treatment and the TH-X HMW system for liver tumor interventions.
Market Leadership and Innovation

These NMPA clearances underscore TrueHealth Medical's significant achievements in percutaneous puncture and ablation robotic systems. The TH-S model itself has been accredited by the NMPA as a China-first innovation, highlighting the company's commitment to pioneering advancements in the field.
Industry Recognition

Nationwide, a total of 21 percutaneous surgical robotic systems have received NMPA approval. TrueHealth Medical's five approved systems represent a substantial portion of this total, reinforcing its leading position in a market segment characterized by strong investor interest and significant growth potential.

Reading history

Hide →

This history is cleared when the page is closed.

How many of TrueHealth’s percutaneous robotic systems have nationwide NMPA approvals?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends